GW&K Investment Management, LLC

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1082917 BOSTON, MA

Position in AGIO

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$41,100,100

+$8,237,368 QoQ

Shares Held

1,214,901

+0.6% QoQ

Ownership

2.04%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 96% Shared 4% None 0%

Healthcare · as of Mar 31, 2026

GW&K Investment Management, LLC holds $699,704,251 across 25 Biotechnology names. AGIO ranks #8 (5.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	623,048	$101,880,808
2	HALO	Halozyme Therapeutics, Inc.	1,393,875	$90,086,140
3	BBIO	BridgeBio Pharma, Inc.	962,643	$71,485,868
4	JAZZ	Jazz Pharmaceuticals plc	371,098	$70,156,076
5	CRNX	Crinetics Pharmaceuticals, Inc.	1,618,686	$58,790,674
6	IONS	Ionis Pharmaceuticals Inc	779,349	$58,521,315
7	VCEL	Vericel Corp	1,616,855	$52,014,225
8	AGIO	Agios Pharmaceuticals, Inc. This page	1,214,901	$41,100,100

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$41,100,100	1,214,901	+0.6%	Shares	Sole	2026-05-13
2025-12-31	$32,862,732	1,207,301	+41.5%	Shares	Sole	2026-02-11
2025-09-30	$34,237,091	852,942	-1.8%	Shares	Sole	2025-11-12
2025-06-30	$28,890,233	868,618	+6.2%	Shares	Sole	2025-08-11
2025-03-31	$23,953,511	817,526	+19.6%	Shares	Sole	2025-05-05
2024-12-31	$22,458,594	683,463	+8.3%	Shares	Sole	2025-02-05
2024-09-30	$28,032,930	630,946	+6.0%	Shares	Sole	2024-11-07
2024-06-30	$25,659,245	595,066	-8.4%	Shares	Sole	2024-08-12
2024-03-31	$18,988,016	649,385	—	Shares	Sole	2024-05-08
No filing history on record for this holder in this stock.